For the period Janaury 2017 to March 2018, a total of 63 samples were submitted to the WRLFMD for FMDV detection and serotyping from Hong Kong, Israel, Kenya, Mongolia, Nepal, Palestinian Autonomous Territories and Swaziland.

There were no outstanding samples that were received in the January to March 2017 period.